BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 18485022)

  • 21. Current treatment practices in the management of cutaneous haemangioma.
    Chan YC
    Expert Opin Pharmacother; 2004 Sep; 5(9):1937-42. PubMed ID: 15330731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Topical imiquimod treatment of cutaneous vascular disorders in pediatric patients: clinical evaluation on the efficacy and safety.
    Mao XH; Wang JY; Yan JL
    J Zhejiang Univ Sci B; 2012 Sep; 13(9):745-50. PubMed ID: 22949365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful treatment of persistent melanoma in situ with 5% imiquimod cream.
    Muñoz CM; Sánchez JL; Martín-García RF
    Dermatol Surg; 2004 Dec; 30(12 Pt 2):1543-5. PubMed ID: 15606836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pilot study using topical imiquimod 5% cream in the treatment of nodular basal cell carcinoma after initial treatment with curettage.
    Neville JA; Williford PM; Jorizzo JL
    J Drugs Dermatol; 2007 Sep; 6(9):910-4. PubMed ID: 17941362
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of difficult infantile haemangiomas.
    Maguiness SM; Frieden IJ
    Arch Dis Child; 2012 Mar; 97(3):266-71. PubMed ID: 22215816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Imiquimod 5% cream in the treatment of mycosis fungoides--a pilot study.
    Chong A; Loo WJ; Banney L; Grant JW; Norris PG
    J Dermatolog Treat; 2004 Apr; 15(2):118-9. PubMed ID: 15204164
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment of lymphangioma circumscriptum with topical imiquimod 5% cream.
    Wang JY; Liu LF; Mao XH
    Dermatol Surg; 2012 Sep; 38(9):1566-9. PubMed ID: 22805499
    [No Abstract]   [Full Text] [Related]  

  • 28. Limited extent AIDS-related cutaneous Kaposi's sarcoma responsive to imiquimod 5% cream.
    Rosen T
    Int J Dermatol; 2006 Jul; 45(7):854-6. PubMed ID: 16863526
    [No Abstract]   [Full Text] [Related]  

  • 29. Imiquimod for the treatment of Bowen's disease and invasive squamous cell carcinoma.
    Nouri K; O'Connell C; Rivas MP
    J Drugs Dermatol; 2003 Dec; 2(6):669-73. PubMed ID: 14711149
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of 5% imiquimod cream in the treatment of facial basal cell carcinoma: a 3-year retrospective follow-up study.
    Vun Y; Siller G
    Australas J Dermatol; 2006 Aug; 47(3):169-71. PubMed ID: 16866996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful treatment with topical imiquimod of anal Buschke-Löwenstein tumor in a child.
    Anissa Z; Houda HG; Wafa K; Olfa M; Rym BM; Achraf D; Samy F
    Dermatol Ther; 2015; 28(6):363-5. PubMed ID: 26179407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topical combination therapy for cutaneous squamous cell carcinoma in situ with 5-fluorouracil cream and imiquimod cream in patients who have failed topical monotherapy.
    Ondo AL; Mings SM; Pestak RM; Shanler SD
    J Am Acad Dermatol; 2006 Dec; 55(6):1092-4. PubMed ID: 17097406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Topical imiquimod therapy for basal and squamous cell carcinomas: a clinical experience.
    Tillman DK; Carroll MT
    Cutis; 2007 Mar; 79(3):241-8. PubMed ID: 17674590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Topical propranolol for infantile haemangiomas: a systematic review.
    Price A; Rai S; Mcleod RWJ; Birchall JC; Elhassan HA
    J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2083-2089. PubMed ID: 29569772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of patch and plaque stage mycosis fungoides with imiquimod 5% cream.
    Deeths MJ; Chapman JT; Dellavalle RP; Zeng C; Aeling JL
    J Am Acad Dermatol; 2005 Feb; 52(2):275-80. PubMed ID: 15692473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Localized pemphigus foliaceus induced by topical imiquimod treatment.
    Lin R; Ladd DJ; Powell DJ; Way BV
    Arch Dermatol; 2004 Jul; 140(7):889-90. PubMed ID: 15262711
    [No Abstract]   [Full Text] [Related]  

  • 37. Efficacy and safety of 5% imiquimod cream in treating patients with multiple superficial basal cell carcinomas.
    Marks R; Owens M; Walters SA;
    Arch Dermatol; 2004 Oct; 140(10):1284-5. PubMed ID: 15492200
    [No Abstract]   [Full Text] [Related]  

  • 38. Use of systemic corticosteroids in management of a large congenital haemangioma of the scalp.
    Hackett BC; Phelan E; Ryan A; Kenny L; Murphy M; Irvine AD; Watson RM
    Pediatr Dermatol; 2013; 30(6):e121-4. PubMed ID: 23004357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Open study of the efficacy and mechanism of action of topical imiquimod in basal cell carcinoma.
    Vidal D; Matías-Guiu X; Alomar A
    Clin Exp Dermatol; 2004 Sep; 29(5):518-25. PubMed ID: 15347339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 5% imiquimod cream for the treatment of large superficial basal cell carcinoma.
    Shumack S; Gebauer K; Quirk C; Macdonald K; Walters SA; Owens M
    Arch Dermatol; 2004 Oct; 140(10):1286-7. PubMed ID: 15492202
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.